Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: Steroid therapy resolved cytopenias and all immune disorders

Internal Medicine

Volumn 40, Issue 10, 2001, Pages 1041-1044

  Funato, K ^a   Kuriyama, Y ^a   Uchida, Y ^a   Suzuki, A ^a   Miyazawa, K ^a   Ohyashiki, K ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoimmune disease; Autoimmune hemolytic anemia; Autoimmune thrombocytopenic purpura; Rheumatoid arthritis

Indexed keywords

PREDNISONE; STEROID;

ADDISON DISEASE; AGED; ANOREXIA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL EXAMINATION; COMORBIDITY; CYTOPENIA; DRUG RESPONSE; FATIGUE; FEMALE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOPATHOLOGY; MYELODYSPLASTIC SYNDROME; REFRACTORY ANEMIA; RHEUMATOID ARTHRITIS; STEROID THERAPY; SYMPTOM; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; WEIGHT REDUCTION;

EID: 0034765131     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.1041     Document Type: Article

References (11)

1. Immunologic abnormalities in myelodysplastic syndromes
2. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease
3. Proposals for the classification of the myelodysplastic syndromes
4. International scoring system for evaluating prognosis in myelodysplastic syndromes
5. Autoimmune Phenomena in Patients with myelodysplastic Syndromes
6. Immune-mediated complications in patients with myelodysplastic syndromes-clinical and cytogenetic features
7. Associated autoimmunity in Addison's Disease
8. Incomplete-form of Behçet Disease in a case of monopathic myelodysplastic myndrome presenting as a thrombocytopenia
9. Morphology and classification of myelodysplastic syndromes
10. Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: Case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome
11. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: Response to immunosuppressive therapy